PARP inhibition in UV-associated angiosarcoma preclinical models

PURPOSE: Angiosarcoma (AS) is a rare vasoformative sarcoma, with poor overall survival and a high need for novel treatment options. Clinically, AS consists of different subtypes, including AS related to previous UV exposure (UV AS) which could indicate susceptibility to DNA damage repair inhibition....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Cancer Res Clin Oncol
Main Authors: Weidema, Marije E., Desar, Ingrid M. E., Hillebrandt-Roeffen, Melissa H. S., van Erp, Anke E. M., Masuzawa, Mikio, Flucke, Uta E., van der Graaf, Winette T. A., Versleijen-Jonkers, Yvonne M. H.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2021
Assuntos:
Original Article – Cancer Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8310857/
https://ncbi.nlm.nih.gov/pubmed/34085099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-021-03678-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares